Prediction model for cardiovascular disease risk in hemodialysis patients
Authors:
- 6 September 2021
- journal article
- research article
- Published by Springer Nature in International Urology and Nephrology
- Vol. 54 (5) , 1127-1134
Abstract
Purpose To derive and validate a prediction score for cardiovascular disease (CVD) risk in hemodialysis patients in China. Methods Three hundred and eighty-eight patients with regular hemodialysis for more than 3 months were recruited from January 1, 2015 to September 30, 2019 and followed up till May 31, 2020. We derived a prediction score using all participants as a training data set and validated using a bootstrap validation data set. Discriminatory ability of the prediction score was assessed by the area under the receiver operating characteristic curve (AUC). Results Of 388 patients without CVD at baseline, 132 developed first CVD events during an average follow-up of 3.27 (inter-quartile range = 3.08) years. Of 26 clinical parameters, age, hypertension, diabetes and abnormal white blood cell (WBC) count were identified as significant predictors and included in the prediction model. Compared to those without any of these risk factors, those with one, two, and three to four points showed increased risks of CVD, with the adjusted hazards ratio and 95% confidence interval (CI) being 3.29 (1.17–9.26), 7.42 (2.68–20.51) and 15.43 (5.44–43.75), respectively. The score showed satisfactory discriminatory ability in both training and validation data set (AUC = 0.7025, 95% CI 0.6520–0.7530, and 0.6876, 95% CI 0.6553–0.7200, respectively). Conclusion We derived and validated a prediction score for CVD risk in hemodialysis patients in China. Given there is a rapid increase in the number of hemodialysis patients, this simple point score can be used to identify high-risk individuals in clinical practice for more precise and efficient personalized treatment.Keywords
Funding Information
- major science and technology projects in 13th five-year (2018ZX10715004-001-009)
- Natural Science Foundation of Guangdong (2018A030310272)
- Guangdong Medical Science and Technology Research Fund (A2018366)
- 3rd affiliated hospital of sun yat-sen university, clinical research program (P000-277)
- Meizhou science and technology project (2019B0203003)
This publication has 29 references indexed in Scilit:
- Cardiovascular and Noncardiovascular Mortality Among Patients Starting DialysisJAMA, 2009
- Rosuvastatin and Cardiovascular Events in Patients Undergoing HemodialysisNew England Journal of Medicine, 2009
- Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trialsThe Lancet, 2009
- Serum fibrinogen levels are an independent predictor of mortality in patients with chronic kidney disease (CKD) stages 3 and 4Kidney International, 2008
- C-Reactive Protein Predicts Vascular Access Thrombosis in Hemodialysis PatientsBlood Purification, 2006
- C-reactive protein as predictor of death in end-stage diabetic nephropathy: Role of peripheral arterial diseaseKidney International, 2005
- Physical functioning in end‐stage renal disease patients: Update 2005Hemodialysis International, 2005
- Framingham risk score and prediction of lifetime risk for coronary heart diseaseThe American Journal of Cardiology, 2004
- Presentation of multivariate data for clinical use: The Framingham Study risk score functionsStatistics in Medicine, 2004
- White blood cells as a novel mortality predictor in haemodialysis patientsNephrology Dialysis Transplantation, 2003